A Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant Tuberculosis
about
Current trends and intricacies in the management of HIV-associated pulmonary tuberculosisUse of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerationsBedaquiline as part of combination therapy in adults with pulmonary multi-drug resistant tuberculosis.Understanding pharmacokinetics to improve tuberculosis treatment outcome.Bedaquiline: A Novel Antitubercular Agent for the Treatment of Multidrug-Resistant Tuberculosis.Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time.Structural Simplification of Bedaquiline: the Discovery of 3-(4-(N,N-Dimethylaminomethyl)phenyl)quinoline-Derived Antitubercular Lead Compounds.In Vitro Activity of Bedaquiline against Nontuberculous Mycobacteria in ChinaPredicted Structures of the Proton-Bound Membrane-Embedded Rotor Rings of the Saccharomyces cerevisiae and Escherichia coli ATP Synthases.Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB?Issues in design and interpretation of MDR-TB clinical trials: report of the first Global MDR-TB Clinical Trials Landscape Meeting.Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure-Activity Relationship and Target Identification Studies.A structure-based strategy toward the development of novel candidates for antimycobacterial activity: Synthesis, biological evaluation, and docking study.Antimycobacterial Activities of N-Substituted-Glycinyl 1H-1,2,3-Triazolyl Oxazolidinones and Analytical Method Development and Validation for a Representative Compound.Quantifying the impact of drug combination regimens on TB treatment efficacy and multidrug resistance probability.New synthetic approaches towards analogues of bedaquiline.Design, synthesis and biological evaluation of 5'-C-piperidinyl-5'-O-aminoribosyluridines as potential antibacterial agents.Challenging the Drug-Likeness Dogma for New Drug Discovery in Tuberculosis
P2860
Q28069032-480A0309-DA6C-4516-8729-D15C71C71FACQ28072205-6D1757E3-78E6-46AC-91A2-0BCB95B37E0BQ30249515-3B40C0EC-18CB-4DE7-8D1A-443B67EE7C79Q30411703-8C770B2D-2C97-484F-8E3C-F827EA2F969FQ37266676-E528863B-D612-4192-8FD3-CEA4AB679CF7Q37619123-E27D6A07-FEBD-4637-A73A-E753F421D22EQ37631895-05CB3014-D781-487F-9AFF-A48465EA51CDQ38938704-21CEC7C3-85E3-4252-B58C-AB694D7DEE98Q39313354-720A1896-1746-4377-B8FA-AFD232CB3964Q40076101-A060F5DD-98BC-4064-B13D-7A2BC7A64912Q45922051-CD025E57-1D4B-420F-B0C0-693676AD0C8CQ46532888-B4C48294-AD37-4B55-8D43-600474EBD19BQ47410563-F6C8A306-637E-4FBE-B728-51D03E448920Q48250652-F0E0F4B4-DA4E-4971-9772-26D7574FD0EBQ50862469-FED77125-4984-4E81-93EB-C34D4B4DA496Q53767185-E65FCE1E-6512-472E-889F-554044253A72Q53837161-15A76939-74BF-4EAA-AFD6-E1C73AD52CE2Q57656314-BA55275A-B737-440F-A0E8-862B2027F7BD
P2860
A Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant Tuberculosis
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A Review of the Evidence for U ...... ti-Drug Resistant Tuberculosis
@ast
A Review of the Evidence for U ...... ti-Drug Resistant Tuberculosis
@en
type
label
A Review of the Evidence for U ...... ti-Drug Resistant Tuberculosis
@ast
A Review of the Evidence for U ...... ti-Drug Resistant Tuberculosis
@en
prefLabel
A Review of the Evidence for U ...... ti-Drug Resistant Tuberculosis
@ast
A Review of the Evidence for U ...... ti-Drug Resistant Tuberculosis
@en
P2860
P1476
A Review of the Evidence for U ...... ti-Drug Resistant Tuberculosis
@en
P2093
Gregory J Fox
P2860
P2888
P304
P356
10.1007/S40121-013-0009-3
P50
P577
2013-08-02T00:00:00Z
P5875
P6179
1016061198